Homology Medicines, Inc. (FIXX) Social Stream
HOMOLOGY MEDICINES INC (FIXX) Price Targets From Analysts
Use the tables below to see what analysts covering HOMOLOGY MEDICINES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 6 | $30.001 | $8 | $23 | $0.97 | 2271.13% |
| 2022-01-31 | 6 | $30 | $8 | $22 | $0.97 | 2168.04% |
| 2022-02-22 | 8 | $30 | $8 | $23.4 | $0.97 | 2312.37% |
| 2022-03-25 | 8 | $29 | $8 | $16.2 | $0.97 | 1570.1% |
| 2022-03-30 | 8 | $29 | $4 | $15.4 | $0.97 | 1487.63% |
| 2022-05-16 | 8 | $29 | $4 | $14 | $0.97 | 1343.3% |
| 2022-08-13 | 8 | $29 | $4 | $13.833 | $0.97 | 1326.08% |
| 2022-08-22 | 8 | $20 | $4 | $10.166 | $0.97 | 948.04% |
| 2022-09-17 | 9 | $20 | $4 | $10 | $0.97 | 930.93% |
| 2022-11-11 | 9 | $20 | $3 | $9 | $0.97 | 827.84% |
| 2022-11-17 | 8 | $20 | $3 | $8.75 | $0.97 | 802.06% |
| 2023-02-08 | 9 | $20 | $3 | $8.75 | $0.97 | 802.06% |
| 2023-03-12 | 8 | $20 | $2 | $8.375 | $0.97 | 763.4% |
| 2023-03-16 | 9 | $20 | $2 | $8.375 | $0.97 | 763.4% |
| 2023-05-15 | 9 | $20 | $2 | $8.571 | $0.97 | 783.61% |
The Trend in the Analyst Price Target
Over the past 36 months, FIXX's average price target has gone down $24.07.
FIXX reports an average of 494.13% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-09-17 | 9 | 20 | 4 | 10.000 | 1.84 | 443.48% |
| 2022-11-17 | 9 | 20 | 3 | 8.750 | 2.01 | 335.32% |
| 2022-11-17 | 8 | 20 | 3 | 8.750 | 2.01 | 335.32% |
| 2023-02-08 | 9 | 20 | 3 | 8.750 | 1.48 | 491.22% |
| 2023-03-12 | 8 | 20 | 2 | 8.375 | 1.23 | 580.89% |
FIXX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 6 | 0 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
FIXX's average broker recommendation rating worsened by 0.29 over the prior 39 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how HOMOLOGY MEDICINES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1844.44% of that group.
- In terms of how HOMOLOGY MEDICINES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1710.91% of that group.
- HOMOLOGY MEDICINES INC's number of analysts covering the stock is greater than 1706.81% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, HOMOLOGY MEDICINES INC's average analyst price target is greater than 455.5% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HOMOLOGY MEDICINES INC are BTAI, IFRX, and MBIO.
View All Top Stocks by Price Target
What is the outlook for FIXX? Use POWR Ratings for clearer insight into price direction.